Medical note: This article is for general education only. CBN products are not proven treatments for insomnia, pain, cancer, seizures, glaucoma, or other diseases. Do not replace prescribed treatment with a cannabinoid product without speaking with a qualified healthcare professional.
Cannabinol (CBN) is a cannabinoid found in cannabis, usually in small amounts. Interest in CBN has grown because products are marketed for sleep, relaxation, pain, and other health goals. However, marketing claims have moved much faster than the clinical evidence. Human research is still limited, and many proposed benefits come from laboratory or animal studies rather than well-designed trials in people.
What Is CBN?
CBN can form as delta-9-tetrahydrocannabinol (THC) is exposed to oxygen, light, or heat over time. It interacts with the body’s endocannabinoid system, but its effects are not identical to THC or cannabidiol (CBD). Claims that CBN is completely non-intoxicating or that it has predictable effects at common commercial doses are too strong because human data remain limited.
Does CBN Help With Sleep?
Sleep is the best-studied reason people use CBN, but the evidence is still developing.
A 2021 review concluded that there was not enough published clinical evidence at that time to support sleep-promoting claims for CBN. A later randomized trial of 293 adults with poor sleep found that 20 mg CBN reduced nighttime awakenings and overall sleep disturbance compared with placebo, but the improvement in the study’s primary sleep-quality outcome was not statistically significant. Another small 2026 randomized crossover trial in 20 adults with insomnia found that a single 300 mg dose improved some sleep measures but did not significantly improve the study’s primary measure of wake time after sleep onset. That study also reported many mild-to-moderate adverse events.
These findings are interesting, but they are not enough to establish CBN as a standard treatment for insomnia. Larger, longer studies are needed to understand effectiveness, dosing, side effects, interactions, and long-term safety.
What About Pain, Inflammation, Seizures, Cancer, Glaucoma, or Brain Health?
CBN has been studied in laboratory and animal models for several biological effects. However, early preclinical findings should not be presented as proven health benefits in people.
- Pain and inflammation: Some preclinical research suggests possible activity, but there is not enough high-quality human evidence to recommend CBN as a treatment.
- Seizures: CBN should not be promoted as an epilepsy treatment. FDA-approved cannabinoid therapy for specific seizure disorders involves prescription cannabidiol, not over-the-counter CBN products.
- Cancer: Laboratory findings do not show that CBN treats cancer in humans. People with cancer should not delay or replace evidence-based treatment because of unproven cannabinoid claims.
- Glaucoma: There is not enough evidence to recommend CBN as a glaucoma treatment. Untreated glaucoma can permanently damage vision and requires professional eye care.
- Neurodegenerative diseases: Claims about ALS, Alzheimer’s disease, Parkinson’s disease, or general ‘neuroprotection’ are not supported by adequate clinical evidence.
- Bone, skin, or appetite benefits: Proposed effects remain preliminary and should not be treated as established therapeutic uses.
Are CBN Products FDA Approved?
In the United States, CBN products marketed for treating diseases generally have not gone through the FDA drug-approval process for those uses. The FDA has issued warning letters involving products containing CBN when companies marketed them with unapproved therapeutic claims.
This matters because an unapproved product may not have been evaluated for an effective dose, reliable manufacturing quality, medication interactions, contamination, or long-term safety.
Possible Risks and Unknowns
Research on CBN safety is much smaller than the evidence base for many approved medicines. Depending on the formulation, cannabinoid products may also contain CBD, THC, or other ingredients that change their effects.
Potential concerns include:
- Drowsiness or impaired alertness
- Dizziness or other nervous-system effects
- Unexpected effects from THC or other cannabinoids in the product
- Interactions with prescription medicines
- Product-label inaccuracies or contamination
- Unknown risks with long-term use
Do not drive, operate machinery, or perform safety-sensitive work if a cannabinoid product makes you drowsy, dizzy, or impaired.
Who Should Be Especially Cautious?
Speak with a healthcare professional before using a CBN-containing product if you:
- Are pregnant, trying to become pregnant, or breastfeeding
- Take prescription medicines, especially sedating medicines
- Have significant liver, kidney, heart, psychiatric, neurologic, or other chronic medical conditions
- Have a history of substance use disorder
- Are considering CBN for a serious condition such as cancer, epilepsy, glaucoma, or a neurodegenerative disease
- Are an older adult or are at increased risk of falls
How to Evaluate CBN Marketing Claims
Be skeptical when a product promises to cure disease, replace a prescription medicine, work ‘without side effects,’ or provide a long list of unrelated benefits. Those are warning signs that the marketing may be stronger than the evidence.
If you are considering a cannabinoid product, ask:
- Has this exact product been tested in human clinical trials?
- Does the company provide independent laboratory testing for cannabinoid content and contaminants?
- Are the claimed benefits supported by peer-reviewed human research?
- Could it interact with my medicines or medical conditions?
Bottom Line
CBN is an interesting cannabinoid, but it should not be described as a proven multi-purpose treatment. Early human sleep studies provide some preliminary signals, yet evidence remains limited and inconsistent. Claims involving cancer, epilepsy, glaucoma, neurodegenerative disease, pain, inflammation, bone health, or other conditions are not established clinical benefits.
If sleep or another symptom is affecting your health, discuss it with a qualified clinician rather than relying on an unproven product claim.
Sources
- PubMed: Cannabinol and Sleep — Separating Fact from Fiction
- PubMed: Randomized placebo-controlled study of CBN with and without CBD on sleep quality
- PubMed: Cannabinol for acute treatment of insomnia disorder
- U.S. FDA: Warning Letters for Cannabis-Derived Products
- U.S. FDA: Cannabis-Derived Products — Safety and Unproven Claims
Last reviewed for medical accuracy: September 2026.